Terray Therapeutics Strengthens Leadership with Appointment of Bassil Dahiyat, Ph.D., as Board Independent Director

Bassil Dahiyat, Ph.D., CEO of Xencor and biotech industry leader, joins the Board of Directors PASADENA, Calif., Nov. 30, 2022 /PRNewswire/ — Terray Therapeutics, a biotechnology company accelerating drug discovery through the application of computational approaches to precisely…